Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Imatinib Mylan
Imatinib mesilate 119.5mg equivalent to Imatinib free base 100mg
Film coated tablet
Mylan New Zealand Limited
Mylan LLC, Puerto Rico, Caguas, Puerto Rico
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Imatinib Mylan
Imatinib mesilate 478mg equivalent to Imatinib free base 400mg
Film coated tablet
Mylan New Zealand Limited
Mylan LLC, Puerto Rico, Caguas, Puerto Rico
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Oxycodone Actavis
Oxycodone hydrochloride 50mg/mL
Concentrate for injection
Actavis New Zealand Limited
CP Pharmaceuticals Limited, Wrexham, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
ViruPOS
Aciclovir 30mg/g
Eye ointment
AFT Pharmaceuticals Limited
Ursapharm Arzneimittel GmbH, Saarbrucken, Germany
|
Dated this 25th day of September 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz